Abstract
We present a case of recurrent infection (infective spondilitis, psoas abscess, and bacteraemia) caused by a single strain of cefotaxime- and ciprofloxacin-resistant and bla(CMY-2)-containing Salmonella enterica serotype choleraesuis during a 4-month period in a patient with uremia. The patient was successfully treated with imipenem for 7 weeks. Our observation indicates that a carbapenem might be considered as a drug of choice for the treatment of infections caused by this emerging multi-resistant pathogen.
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use*
-
Bacteremia / drug therapy
-
Bacteremia / microbiology
-
Cefotaxime / pharmacology*
-
Ciprofloxacin / pharmacology*
-
Drug Resistance, Multiple, Bacterial*
-
Female
-
Humans
-
Imipenem / therapeutic use*
-
Middle Aged
-
Psoas Abscess / drug therapy
-
Psoas Abscess / microbiology
-
Recurrence
-
Salmonella Infections / drug therapy
-
Salmonella Infections / microbiology
-
Salmonella enterica / classification
-
Salmonella enterica / drug effects*
-
Spondylitis / drug therapy
-
Spondylitis / microbiology
-
Treatment Outcome
-
Uremia / drug therapy*
-
Uremia / microbiology
Substances
-
Anti-Bacterial Agents
-
Ciprofloxacin
-
Imipenem
-
Cefotaxime